Literature DB >> 16937270

Age-related changes in bone biochemical markers and their relationship with bone mineral density in normal Chinese women.

Yin-Zhen Pi1, Xian-Ping Wu, Shi-Ping Liu, Xiang-Hang Luo, Xing-Zhi Cao, Hui Xie, Er-Yuan Liao.   

Abstract

Measurements of bone biochemical markers are increasingly being used to evaluate the state of bone turnover in the management of bone metabolic diseases, especially osteoporosis. However, changes in the bone turnover rate vary with age. The aim of this study was to establish the laboratory reference range of serum bone-specific alkaline phosphatase (sBAP), serum type I collagen cross-linked C-terminal telopeptide (sCTx), and urine CTx (uCTx), based on values from 665 healthy Chinese women aged 20-80 years. We measured the levels of sBAP, sCTx, serum alkaline phosphatase (sALP), and uCTx and evaluated the age-related changes and their relationship with bone mineral density (BMD) in the anteroposterior (AP) lumbar spine, hip, and left forearm. We found significant correlations between biochemical markers and age, with coefficients of determination (R (2)) of 0.358 for sBAP, 0.126 for sCTx, 0.125 for uCTx, and 0.336 for sALP. The net changes in different biochemical markers were inversely correlated with the rates of BMD loss in the AP lumbar spine. After correction for age, body weight, and height, the levels of the markers had significant negative correlations with the BMD of the AP lumbar spine, femoral neck, and ultradistal forearm. All four biochemical markers had the highest negative correlation with BMD of the AP lumbar spine (partial correlation coefficients of -0.366, -0.296, -0.290, and -0.258 for sBAP, sCTx, uCTx, and sALP, respectively). The mean and SD values of these markers in premenopausal and postmenopausal women with normal BMD values were used as the normal reference ranges. The reference ranges of sBAP, sCTx, and uCTx for pre- vs postmenopausal women were 17.3 +/- 6.23 vs 18.9 +/- 7.52 U/l, 3.18 +/- 1.49 vs 3.23 +/- 1.57 nmol/l, and 15.5 +/- 11.4 vs 16.2 +/- 12.4 nM bone collagen equivalents/mM urinary creatinine, respectively. Levels of the bone formation marker (sBAP) and bone resorption markers (sCTx, uCTx) increased rapidly in women with osteopenia or osteoporosis, indicating that they may be sensitive markers to determine the bone turnover rate in healthy Chinese women.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16937270     DOI: 10.1007/s00774-006-0703-2

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  31 in total

1.  The predictive value of biochemical markers of bone turnover for bone mineral density in postmenopausal Japanese women.

Authors:  O Chaki; I Yoshikata; R Kikuchi; M Nakayama; Y Uchiyama; F Hirahara; I Gorai
Journal:  J Bone Miner Res       Date:  2000-08       Impact factor: 6.741

2.  Hormone replacement therapy in postmenopausal women: urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response of bone mineral density.

Authors:  C H Chesnut; N H Bell; G S Clark; B L Drinkwater; S C English; C C Johnson; M Notelovitz; C Rosen; D F Cain; K A Flessland; N J Mallinak
Journal:  Am J Med       Date:  1997-01       Impact factor: 4.965

3.  Changes in biochemical markers of osteoblastic activity during the menstrual cycle.

Authors:  H K Nielsen; K Brixen; R Bouillon; L Mosekilde
Journal:  J Clin Endocrinol Metab       Date:  1990-05       Impact factor: 5.958

4.  Case-control analysis of bone resorption markers, disability, and hip fracture risk: the Rotterdam study.

Authors:  P L van Daele; M J Seibel; H Burger; A Hofman; D E Grobbee; J P van Leeuwen; J C Birkenhäger; H A Pols
Journal:  BMJ       Date:  1996-02-24

5.  Biochemical markers as predictors of rates of bone loss after menopause.

Authors:  A Rogers; R A Hannon; R Eastell
Journal:  J Bone Miner Res       Date:  2000-07       Impact factor: 6.741

6.  Rapid bone loss is associated with increased levels of biochemical markers.

Authors:  P D Ross; W Knowlton
Journal:  J Bone Miner Res       Date:  1998-02       Impact factor: 6.741

7.  Biochemical markers of bone resorption compared with estimates of bone resorption from radiotracer kinetic studies in osteoporosis.

Authors:  R Eastell; A Colwell; L Hampton; J Reeve
Journal:  J Bone Miner Res       Date:  1997-01       Impact factor: 6.741

8.  Establishment of BMD reference plots and determination of peak BMD at multiple skeletal regions in mainland Chinese women and the diagnosis of osteoporosis.

Authors:  Xian-Ping Wu; Er-Yuan Liao; Hong Zhang; Peng-Fei Shan; Xing-Zhi Cao; Shi-Ping Liu
Journal:  Osteoporos Int       Date:  2003-11-04       Impact factor: 4.507

9.  Urinary excretion of type I collagen crosslinked N-telopeptides in healthy Japanese adults: age- and sex-related changes and reference limits.

Authors:  T Sone; M Miyake; N Takeda; M Fukunaga
Journal:  Bone       Date:  1995-10       Impact factor: 4.398

10.  Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment.

Authors:  P Garnero; W J Shih; E Gineyts; D B Karpf; P D Delmas
Journal:  J Clin Endocrinol Metab       Date:  1994-12       Impact factor: 5.958

View more
  11 in total

1.  Differential effects of calcium- and vitamin D-fortified milk with FOS-inulin compared to regular milk, on bone biomarkers in Chinese pre- and postmenopausal women.

Authors:  Marlena C Kruger; Yoke Mun Chan; Barbara Kuhn-Sherlock; Lee Ting Lau; ChinChin Lau; Y S Chin; Joanne M Todd; Linda M Schollum
Journal:  Eur J Nutr       Date:  2015-08-12       Impact factor: 5.614

2.  Estimation of serum osteocalcin and telopeptide-C in postmenopausal osteoporotic females.

Authors:  M Lateef; M Baig; A Azhar
Journal:  Osteoporos Int       Date:  2009-07-14       Impact factor: 4.507

3.  Reference intervals of serum tartrate-resistant acid phosphatase type 5b activity measured with a novel assay in Japanese subjects.

Authors:  Yoshiki Nishizawa; Masaaki Inaba; Mitsukazu Ishii; Hiroyuki Yamashita; Takami Miki; Hitoshi Goto; Sinsuke Yamada; Osamu Chaki; Kentaro Kurasawa; Yoshiko Mochizuki
Journal:  J Bone Miner Metab       Date:  2008-05-11       Impact factor: 2.626

Review 4.  Bone physiology, disease and treatment: towards disease system analysis in osteoporosis.

Authors:  Teun M Post; Serge C L M Cremers; Thomas Kerbusch; Meindert Danhof
Journal:  Clin Pharmacokinet       Date:  2010       Impact factor: 6.447

5.  Calcium and vitamin D fortified milk reduces bone turnover and improves bone density in postmenopausal women over 1 year.

Authors:  Marlena C Kruger; Yoke Mun Chan; Lee Ting Lau; Chin Chin Lau; Yit Siew Chin; Barbara Kuhn-Sherlock; Joanne M Todd; Linda M Schollum
Journal:  Eur J Nutr       Date:  2017-10-03       Impact factor: 5.614

6.  Bone turnover biomarkers and risk of osteoporotic hip fracture in an Asian population.

Authors:  Zhaoli Dai; Renwei Wang; Li-Wei Ang; Jian-Min Yuan; Woon-Puay Koh
Journal:  Bone       Date:  2015-11-07       Impact factor: 4.398

Review 7.  Metabolomics and Its Application in the Development of Discovering Biomarkers for Osteoporosis Research.

Authors:  Huanhuan Lv; Feng Jiang; Daogang Guan; Cheng Lu; Baosheng Guo; Chileung Chan; Songlin Peng; Baoqin Liu; Wenwei Guo; Hailong Zhu; Xuegong Xu; Aiping Lu; Ge Zhang
Journal:  Int J Mol Sci       Date:  2016-12-02       Impact factor: 5.923

8.  The association between bone turnover markers and microvascular complications of type 2 diabetes.

Authors:  Zhila Maghbooli; Parisa Shabani; Sattar Gorgani-Firuzjaee; Arash Hossein-Nezhad
Journal:  J Diabetes Metab Disord       Date:  2016-11-07

9.  Effect of Altering Dietary n-6:n-3 Polyunsaturated Fatty Acid Ratio with Plant and Marine-Based Supplement on Biomarkers of Bone Turnover in Healthy Adults.

Authors:  Sujatha Rajaram; Ellen Lan Yip; Rajneesh Reghunathan; Subburaman Mohan; Joan Sabaté
Journal:  Nutrients       Date:  2017-10-24       Impact factor: 5.717

10.  Reference Intervals for Bone Turnover Markers in Korean Healthy Women.

Authors:  Dong Hyeok Cho; Jin Ook Chung; Min Young Chung; Jeong-Ran Cho; Dong Jin Chung
Journal:  J Bone Metab       Date:  2020-02-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.